Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Siberian Populations

• Published in: Antibodies (Basel) Vol. 12; no. 4; p. 82
• Main Authors: Shaprova, Olga N., Shanshin, Daniil V., Kolosova, Evgeniia A., Borisevich, Sophia S., Soroka, Artem A., Merkuleva, Iuliia A., Nikitin, Artem O., Volosnikova, Ekaterina A., Ushkalenko, Nikita D., Zaykovskaya, Anna V., Pyankov, Oleg V., Elchaninova, Svetlana A., Shcherbakov, Dmitry N., Ilyicheva, Tatiana N.
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.12.2023
• Subjects: Amino acids; Analysis; Antibodies; Antigens; Breeding grounds; Cell culture; Cloning; coronavirus; Coronaviruses; COVID-19; E coli; Enzyme-linked immunosorbent assay; Herd immunity; Humoral immunity; IgG; Immunoglobulin G; Infections; Lymphocytes; Methods; N protein; Neutralizing; Nucleocapsids; Pandemics; Physiological aspects; Plasmids; pre-existing immunity; Proteins; Public health; SARS-CoV-2; Serum; Severe acute respiratory syndrome coronavirus 2; Viral antibodies; Viral diseases; Viruses; Waterfowl; Russia; United States > US; IgG; coronavirus; SARS-CoV-2; antibodies; pre-existing immunity

In December 2019, a new coronavirus, SARS-CoV-2, was found to in Wuhan, China. Cases of infection were subsequently detected in other countries in a short period of time, resulting in the declaration of the COVID-19 pandemic by the World Health Organization (WHO) on 11 March 2020. Questions about th...